iPSC

Researchers simulated interactions between microbial molecules and neural receptors to explore whether gut bacteria might influence brain chemistry.

Induced pluripotent stem cell-derived microglia generated with precision cell reprogramming technology can create more reliable in vitro assays.

A new iPSC-derived cellular tool with built-in Cas9 expression enables high efficiency knockout screening for drug target identification and validation.

Researchers use a high throughput microelectrode array platform to test neural activity in an in vitro model of ALS.

Researchers used organ chips to mimic conditions that help heart cells mature.

Clive Svendsen, Meritxell Huch, Ameen Salahudeen, and Maksim Plikus will discuss the latest advances in using patient-derived stem cells to create more accurate disease models.

Scientists discover how to convert the brain’s glial cells into multipotent neural stem cells.

Most of the human induced pluripotent stem cells stored at major cell line repositories and used in research harbor thousands of DNA errors, a study finds, highlighting the need for improved quality control measures.

In this webinar, Kim Vanuytsel and Ryan Flannigan will discuss cutting-edge technologies for improving stem cell-based therapies.

Personalized stem cells improved motor symptoms and depression signs in monkeys modeling Parkinson’s disease, paving the way for trials in human patients.

An animal component-free culture medium provides a safe and robust alternative for maintaining induced pluripotent stem cells.

Guidelines for maintaining human cells grown ex vivo

Bryan Black and Lucas Thal will discuss their experiences screening hiPSC-derived neural cells to understand chronic pain and neuroinflammation.

As research and therapeutic applications for pluripotent stem cells (PSCs) grow, so does the need to reliably and cost-effectively generate large numbers of high-quality cells.

Researchers report a new way of generating the cells from induced pluripotent stem cells in hopes they will one day be used in blood transfusions.

Surviving Stress: The mysteries of neuronal survival and neurodegeneration

Biologists have published a DIY recipe for human induced pluripotent stem cell maintenance, which they estimate costs 3 percent of commercial media prices.

To advance the possibility of off-the-shelf cardiac cell therapies, scientists devise an engineered cardiac stem cell that avoids stimulating a detrimental immune attack.

Dropping the transcription factor from the four so-called Yamanaka factors reduces the efficiency of inducing the production of stem cells, but the resulting cells are of greater quality.